Zach Yetmar

Transplant ID @ClevelandClinic I Former @MayoClinicINFD & @MayoMN_IMRES | @NEOMEDedu '17 | #1 fan of @PaigeMartyMD

[Zach Yetmar @ZYetmar]

@TxID_Fellows @JosephMarcusID @TakaMatsuo_ID @tmhohl71 @GenPapaMD @RazonableMD @AnnaApostolopo3 @rodolfo_alpizar @TxID_Edu @Admishkin Fellowship is a great time to build skills. It's easy to feel pressure to establish a niche right away, but often having skills for later is invaluable. Like a specific project might not be your "thing", but if you learn a new method then it may still pay off later.

[Zach Yetmar @ZYetmar]

@TxID_Fellows @DrPHO_ID @natetxid @shahidh80523771 @alan_koff @shwetanjan @ClancyNeil @JosephSassineMD @Doctor_Yiannis @HannahImlay @JoshuaHillMD @SAIRABT @vojtek_md It's great when you meet a mentor organically on service, but this can be tough in a short timeframe. Ask your program leadership and see who has a track record of mentorship, especially in your area of interest. You can always have multiple mentors too!

[Zach Yetmar @ZYetmar]

@TxID_Fellows @HansHHirsch1 @Jmsteinbrink @DanielDulekMD @pascalisID @TedRader4MD @NeerajaSwamina2 Start by asking what has already been done by prior fellows. This will give a general idea about what's feasible in one year, and sometimes datasets may already exist that you can build on in a new direction.

[Zach Yetmar @ZYetmar]

@TxID_Fellows @OrlaMorris61218 @RicardoLaHozMD @EileenMaziarz @MadyHeldman @DrAndreKalil @alfred_luk @JennKChow It's easy to overlook, but I'd make sure you have a grasp of the non-ID basics of transplants. Immunosuppression, surgical approaches, common noninfectious complications - these come up often and will be important to know!

[Zach Yetmar @ZYetmar]

@TxID_Fellows @EmilyBlumbergMD @emilymeich @DrNeilStone @ApuAkkad1 @RachelSigler8 @ChemalyRoy @AndrewKaraba @DhandAbhay @camwolfe Being deliberate about getting to know members of the transplant teams. You end up working with a lot of the same people through the year, and knowing who to call from specific transplant teams is invaluable! #TxIDChat

[Zach Yetmar @ZYetmar]

@TxID_Fellows @Mayyadah_HA @TMcCarty2010 @TIDinRVA @niyati_narsana Zach Yetmar at Cleveland Clinic! I'm APD of the general ID fellowship. I did a 3-year fellowship that included a transplant track. Excited to hear everyone's experiences!

[TxID Early Career Network @TxID_Fellows]

1 HOUR until the next #TxIDChat. Calling anyone who has ever done a #TxID fellowship year or runs a program! Please participate to help our amazing trainees going into a career in TID!

@Mayyadah_HA
@ZYetmar
@TMcCarty2010
@TIDinRVA
@niyati_narsana

[TxID Early Career Network @TxID_Fellows]

WE ARE BACKKKK. Get ready for the next #TxIDChat -- on Wednesday, Jan 21st at 730PM EST.

We are excited to announce with co-hosts @Mayyadah_HA and @ZYetmar and several surprise guests on the topic of Maximizing your One Year #TxID Fellowship!

Look forward to seeing you there!

[Ia Bunal @whoolyapow]

Absolutely thankful for the support through the Kass Award @IDSA & @CCF_IMCHIEFS, most esp mentorship by one of the greatest ID staff I’ve ever come to work with @ZYetmar ! 🦠🥸

[CCF ID Fellows @ccf_idfellows]

Dr. Deepali Sharath, our 2nd year ID fellow, presented on zoonotic infections in SOT today at #WTC2025 —an important topic in long-term transplant care, supported by a great team #TransplantID #Zoonoses #InfectiousDiseases
@ZYetmar @infectio01 @i_am_jlum

[transplantid.net @TransplantIDNet]

Happy 4️⃣ 🗓️ of July! Happy Independence Day, USA!🗽

Observe by expressing you opinion!
In this case, a follow-up survey on the transplant 🆔 library https://t.co/BOMS6dj5fu?
💯 % anonymous
🕑 <10 minutes!

Approved @AST_IDCOP and @EinsteinMed IRB

https://t.co/BQ60JgdrEw

[CCF ID Fellows @ccf_idfellows]

Congratulations to our transplant ID fellow, Dr. Mayyadah Alabdely, on her research publication 👏
https://t.co/0m6tNjCXI5

@TheTxIDjournal @Mayyadah_HA @ZYetmar #TransplantID #TxID

[Mayyadah Alabdely/ مياده العبدلي @Mayyadah_HA]

I’m happy to share that our paper “Surgical Site Infection After Intestine Transplantation: Risk Factors & Outcomes” is now published
Grateful to everyone who contributed to this project and especially to Dr.Yetmar for his invaluable mentorship
https://t.co/5zKFgch5sT @ZYetmar

[transplantid.net @TransplantIDNet]

Do you use https://t.co/BOMS6dj5fu for #TxID?
Do you have ideas about improving it?

Do you prefer other resources? PubMed, texts, Google Scholar?
Tell us!
⌛ Anonymous survey <10 min⌛
Approved by @AST_IDCOP & @EinsteinMed IRB.

https://t.co/7J4MIhI5gy

[Mayo Clinic Infectious Diseases @MayoClinicINFD]

Publication Alert

State-of-the-Art Review: Modern Approach to Nocardiosis—Diagnosis, Management, and Uncertainties | Clinical Infectious Diseases ⁦@ZYetmar⁩ ⁦@ElenaBeamMD⁩ https://t.co/BXKs1DyVni

[Mayo Clinic Infectious Diseases @MayoClinicINFD]

Publication Alert

As we enter spring and warmer season, this is a reminder that tick-borne infections will soon be upon us.

Here is new data on human anaplasmosis: trends over a decade
@atiplis @omarabusaleh15 @S_chesdachai @ZYetmar

https://t.co/HjMfdRKbrz

[Mayo Clinic Infectious Diseases @MayoClinicINFD]

Publication Alert

What is the role of plasma microbial cell-free DNA sequencing in suspected infective endocarditis? @omarabusaleh15 @SofiaMolina1992 @OFIDJournal @ZYetmar

https://t.co/MUWYvxoYNF

[transplantid.net @TransplantIDNet]

Optimal vaccination is challenging - especially in ICH pts!

New @NEJM @victoriahall26 study assessing flu vax in heme pts: two-dose adjuvanted v standard
💉 Similar seroconversion
💉 Better response in MM, though similar between arms

Find it in vax 📁!

https://t.co/oHOv4lNl8s

[transplantid.net @TransplantIDNet]

🆕 Review of MCS infections @IDClinics @emilymeich @StephaniePouch
❤️‍🔥 PET-CT helpful
❤️‍🔥 BSI ≥72h, MDROs, Candida can indicate device-specific inf
❤️‍🔥 Complicated inf may need suppression

Must-read for those new to LVADs!

Added to LVAD 📁 by @belga_sara

https://t.co/ciYWoi2iNo

[transplantid.net @TransplantIDNet]

Maribavir v. GCV - Resistance!

Subanalysis of pivotal maribavir trial @JIDJournal
Resistance:
💊More common w/ maribavir (10% v 2.5%)
💊Associated with VL ≥9100 IU/mL and refractory inf

In R/R CMV w/ high VL, do you start with maribavir?

Now in CMV 📁

https://t.co/UV5jyewyMQ